Welcome to HemoGAD Technologies

Experts in Hemochromatosis

Welcome to HemoGAD Technologies, a start-up company in the field of medical device research for the management of Hereditary Hemochromatosis (HH) and Anaemia. Hemochromatosis is one of the most prolific, but widely unknown, genetic disorders that remains widely under diagnosed (and mis-diagnosed) today. 

Read our blog from George Donnelly, HemoGAD’s CEO, for regular updates and insights into the fast-evolving field of Hereditary Hemochromatosis (HH) diagnosis and management.


We are proud to be members of Medilink East Midlands.  Medilink UK is a national health technology business support organisation, part funded by government, to encourage innovation in healthcare: https://www.medilinkem.com